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ABSTRACT 
Expression of GPCR fatty acid sensor/receptor genes in adipocytes is modulated by 
inflammatory mediators, particularly IL-1β. In this study we examined whether the IL-1 gene 
superfamily member, IL-33, also regulates expression of the fatty acid receptor genes in 
adipocytes. Human fat cells, differentiated from preadipocytes, were incubated with IL-33 at 
three different dose levels for 3 or 24 h and mRNA measured by qPCR. Treatment with IL-33 
induced a dose-dependent increase in GPR84 mRNA at 3 h, the level with the highest dose 
being 13.7-fold greater than in controls. Stimulation of GPR84 expression was transitory; the 
mRNA level was not elevated at 24 h. In contrast to GPR84, IL-33 had no effect on GPR120 
expression. IL-33 markedly stimulated expression of the IL1B, CCL2, IL6, CXCL2 and CSF3 
genes, but there was no effect on ADIPOQ expression. The largest effect was on CSF3, the 
mRNA level of which increased 183-fold over controls at 3 h with the highest dose of IL-33; 
there was a parallel increase in the secretion of G-CSF protein into the medium. It is concluded 
that in human adipocytes IL-33, which is synthesised in adipose tissue, has a strong stimulatory 
effect on the expression of cytokine and chemokine genes, particularly CSF3, and on the 
expression of GPR84, a pro-inflammatory fatty acid receptor.  
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1. Introduction 
Several G-protein coupled receptors act as sensors/receptors for fatty acids [1-2]. GPR120 (or 
FFAR4), is a receptor for n-3 polyunsaturated fatty acids, and has been linked to the anti-
inflammatory action of these lipids [2-3]. The primary ligands for GPR41 (FFAR3) and GPR43 
(FFAR2) are short chain fatty acids, while GPR40 (FFAR1) is activated by medium and long 
chain saturated and mono-unsaturated fatty acids [1-2]. GPR84 (EX33), a pro-inflammatory 
receptor, is also activated by medium chain fatty acids [4-5]. Each of these GPCRs has a distinct 
tissue distribution, with GPR120 being strongly expressed in both adipocytes and macrophages 
(M1 and M2) in white adipose tissue, where it promotes adipogenesis [6] in addition to insulin 
sensitising and anti-inflammatory actions [2-3]. Adipocytes also express GPR84, and at least in 
the case of human fat cells GPR40, GPR41 and GPR43, albeit at low levels [7].  
Recent studies have shown that the expression of GPR84, GPR41 and GPR120 is 
powerfully and differentially modulated by inflammatory mediators. Macrophage-conditioned 
medium, lipopolysaccharide, TNFα and IL-1β have each been shown to strongly stimulate 
GPR84 expression [4, 7-9]. In contrast, GPR120 expression is markedly reduced by these agents 
[7-8]. IL-1β induces a particularly strong stimulation of GPR84 expression in human adipocytes 
and the expression of GPR41 is also increased [7]. The IL-1 superfamily of cytokines comprises 
other pro-inflammatory agonists in addition to IL-1β, including IL-18 and IL-33 [10], both of 
which are produced by human white adipocytes [10-11]. However, the main source of IL-33 in 
human adipose tissue appears to be endothelial cells [12]. IL-33 has multiple effects in 
inflammation and immunity, involving the stimulation of regulatory T (Treg) cells and the 
production of Th2 cytokines and chemokines such as IL-5, IL-6 and MCP-1, including in 
adipose tissue [13]. 
In view of the link between inflammation and the production of GPCR fatty acid 
receptors in adipocytes, we have examined whether IL-33 modulates the expression of key fatty 
acid receptor genes in human adipocytes, and of cytokine and chemokine genes.  
 
2. Materials and methods 
2.1.  Adipocyte cell culture 
Human preadipocytes, isolated from subcutaneous adipose tissue, and proprietary cell culture 
media were purchased from PromoCell (Germany; Catalogue #C-12730, Lots #419Z023). The 
cells were plated into 12-well plates (5,000 cells/cm2), cultured to confluence, differentiated into 
adipocytes and then further cultured in nutrition medium (changed every 2-3 days) for up to 14 
days, as previously [14]. The nutrition medium contained 3% foetal calf serum, dexamethasone 
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(400 ng/ml) and insulin (0.5 μg/ml). Differentiated adipocytes, characterised by fat droplets, 
were used at 12-14 days after differentiation was induced.  
 The adipocytes were divided into four groups which were incubated with either 0 
(controls), 5, 25 or 100 ng/ml of recombinant IL-33 (Sigma, UK) for 3 or 24 h. The dose levels 
were based on previous studies [13]. Following the incubation period, the medium was aspirated 
and stored at -20oC, and the cells washed and frozen in TRI Reagent (Sigma) prior to storage at  
-80oC. Six individual sets of adipocytes were taken for each group.  
2.2. RNA extraction and real-time PCR 
The adipocytes were thawed and homogenised in the TRI Reagent in which they were stored, 
and RNA extracted using an RNeasy Micro Kit (Qiagen, UK). The purity of the extracted RNA 
was close to 2.0 (260/280 and 260/230 ratios by NanoDrop 1000, Wilmington, USA). The RNA 
was DNAse-treated with a TURBO-DNA-freeTM kit (Ambion, Life Technologies, USA) and 2 μg 
reverse transcribed using Taqman® reverse transcription reagents (Applied Biosystems, UK). 
cDNA (40-80 ng) was taken for real-time PCR which was performed in triplicates using a Gene 
Expression Master Mix and TaqMan® Gene Assays consisting of specific Taqman® probes 
(Applied Biosystems). The following human gene probes were employed: GPR41 
(Hs02519193_g1), GPR84 (Hs01874713_s1), GPR120 (Hs00699184_m1), CCL2 
(Hs00234140_m1), IL1B (Hs01555410_m1), IL6 (Hs00985639_m1), ADIPOQ 
(Hs00605917_m1), CSF3 (Hs00738432_gl), CXCL2 (Hs00601975). ACTB (Hs99999903_m1) 
was the reference gene. PCR reactions were arranged in duplex format with the FAM-labelled 
Taqman® probe for each gene mixed with the VIC-labelled Taqman® probe for ACTB.  
PCR amplification was performed with an ABI real-time PCR detection system (ABI 
StepOneplus, Applied Biosystems) with two-step thermal cycling: 95C for 10 min, followed by 
40 cycles of 95C for 15 sec and 60C for 1 min. Data were analysed by the comparative 2-ΔΔCt 
method, as previously [7, 14] and expressed as fold-changes in the target gene (normalized to 
ACTB) in adipocytes treated with IL-33 in relation to expression in the control cells (control 
cells =1). 
2.3. Protein immunoassays 
The concentration of IL-6 and G-CSF in the culture medium, which was centrifuged to remove 
any cell debris, was measured using sensitive MSD immunoassays (Meso Scale Discovery, USA). 
Plates were pre-coated with antibodies on discrete spots and the assay performed according to 
the manufacturer’s instructions, as previously [7, 14]; data were analysed using Meso Scale 
software. The minimum level of detection was 0.06 pg/ml for IL-6 (interlot CV <20 %) and 1.5 
pg/ml for CSF3 (interlot CV <18%). 
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2.4. Statistical analysis 
The statistical significance of differences between groups was assessed by one-way ANOVA 
with a Bonferroni post-test (for selected groups) or with Student’s unpaired t test. A value of 
P<0.05 was taken as statistically significant. 
 
3. Results 
Human adipocytes, differentiated from fibroblastic preadipocytes in culture, were incubated with 
IL-33 for either 3 or 24 h to examine acute and prolonged responses to the cytokine. Low, 
medium and high concentrations of IL-33 were employed. IL-33 had no significant effect on 
GPR120 mRNA level at either 3 or 24 h, except for a small, but statistically significant, reduction 
for the middle concentration of the cytokine at the shorter time point (Fig 1b). There was also 
no effect of IL-33 on GPR41 mRNA level at 24 h; a small, dose-dependent, increase was evident 
at 3 h, the increase being statistically significant with the highest dose (Fig 1c). In contrast, IL-33 
induced a marked, dose-dependent increase in GPR84 mRNA at 3 h, the level with the high 
dose being 13.7-fold greater than in controls (Fig 1a). This effect was, however, transitory; there 
was no significant change in GPR84 mRNA at 24 h (Fig 1a). 
 To assess the effects of IL-33 on the expression of classical inflammation-related genes, 
the mRNA level of a group of cytokine and chemokines was examined. IL-33 induced a marked, 
dose-dependent increase in mRNA of the ILB, IL6, CCL2, CXCL2 and CSF3 genes at 3 h (Fig 
2a-e). With the highest dose of IL-33, there were 3.0-, 11.7-, 15.2- and 15.6-fold increases in 
mRNA level of the CCL2, IL6, CXCL2 and ILB genes, respectively. CSF3 exhibited a very 
substantial response to IL-33, the mRNA level with the highest dose of the cytokine being 183-
fold higher than in the controls (Fig 2e).  
As with GPR84, these responses to IL-33 were transitory; there was no effect of IL-33 
on IL-1β mRNA at 24 h (Fig 2a), and there was actually a small reduction in CCL2 mRNA with 
the low and medium doses of the cytokine (Fig 2c). CSF3, IL-6 and CXCL2 mRNA levels were 
each elevated at 24 h with the highest dose of IL-33 (3.9-, 2.5- and 3.3-fold, respectively); 
however, for CSF3, the increase was substantially lower than the 183-fold increase at 3 h. 
In contrast to the other adipokine genes, expression of ADIPOQ, which encodes the key 
adipocyte hormone adiponectin, was not modified by IL-33, the mRNA level being unchanged 
at both 3 and 24 h with each dose of the cytokine (Fig 2f). IL18 expression was also unaltered 
(results not shown). 
To determine whether the changes in cytokine and chemokine gene expression were 
reflected by similar changes in secretion of the encoded protein, the effect of IL-33 on the 
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release of IL-6 and G-CSF was examined. Treatment with IL-33 resulted in a dose-dependent 
increase in the amount of the two adipokines in the culture medium at both 3 and 24 h (Fig 2g 
and 2h). The amount of both proteins was greater at 24 h than at 3 h, reflecting the delay 
between increases in mRNA level and release of the protein product. At 24 h, with the highest 
dose of IL-33, the amount of IL-6 was 7.9-fold greater than in the controls (4.7-fold at 3 h) and 
23.9-fold higher (4.6-fold at 3 h) in the case of G-CSF.  
 
4. Discussion 
This study demonstrates that expression of the GPR84 fatty acid receptor/sensor gene in human 
adipocytes is strongly and acutely stimulated by IL-33. This parallels the stimulatory effect of IL-
1β and TNFα, as well as other mediators, on the expression of this gene in fat cells [4, 7-9]. 
GPR84 is considered a pro-inflammatory receptor, its activation amplifying the production of 
IL-8 and IL-12 p40 in polymorphonuclear leukocytes and of TNFα by macrophages [5]. Thus 
IL-33 may contribute to the inflammatory response in adipose tissue in part through increased 
production of GPR84.  
IL-33 did not have a suppressive effect on GPR120 expression, in contrast to TNFα and 
IL-1β [7-8]. The insulin sensitising and anti-inflammatory actions of GPR120, which is a receptor 
for n-3 polyunsaturated fatty acids [2-3], is unlikely to be modified by IL-33 contrary to what has 
been projected with IL-1β and TNFα [7]. The intracellular signalling pathways linked to the IL-
33 receptor, ST2 (and its co-receptor IL-1 receptor accessory protein) [15], which are expressed 
in human adipocytes [11], would appear to be implicated in the modulation of the transcription 
of the GPR84 gene, but not GPR120. It is noted that while 3 and 24 h time-points were 
employed, reflecting potential acute and sustained effects of IL-33, the possibility cannot be 
excluded that some changes might occur at intermediate times, but if so these are likely to be 
limited.   
IL-33 had marked effects on the inflammatory response in human adipocytes beyond 
GPR84, with a substantial stimulation of the expression of a selected group of cytokine and 
chemokine genes. Expression of IL1B, a co-member of the IL-1 superfamily, was strongly up-
regulated by IL-33, as was IL6 and CXCL2 (encoding MCP-1) and CSF3. Stimulation of MCP-1, 
and IL-6 from the stromovascular fraction of murine adipose tissue by IL-33 has been noted 
previously [13]. Stimulation of CSF3 expression was particularly marked in the present study, and 
this was accompanied by a major increase in the secretion of G-CSF into the medium. CSF3 
expression is also strongly up-regulated in human adipocytes by IL-1β [14]. The substantial 
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increase in G-CSF production may be linked to neutrophil recruitment and function in adipose 
tissue, as well as a potential neutrophic/neuroprotective role in inflammation in the tissue.  
In contrast to the other adipokine genes examined, IL-33 had no effect on the expression 
of ADIPOQ. Since adiponectin, the adipocyte hormone encoded by ADIPOQ, has anti-
inflammatory and insulin sensitising functions [see 7], IL-33 does not compromise the 
production of a factor with these actions, unlike IL-1β and TNFα which inhibit ADIPOQ 
expression [7, 14]. As with GPR120, the possibility cannot be excluded of some small response 
to IL-33 at time-points intermediate to 3 and 24 h. 
There are multiple potential sources of IL-33 within adipose tissue, since the IL33 gene is 
expressed in adipocytes, macrophages and endothelial cells [12]. As such, the cytokine may have 
both autocrine and paracrine actions in the tissue. IL33 expression is elevated in adipose tissue 
of obese humans where it is suggested that it may contribute to inflammation in obesity [12], 
However, a protective effect of IL-3 has also been proposed [13, 16]; IL-33 reduces the 
inflammatory response in adipose tissue in obese mice through polarising macrophages to the 
M2 phenotype as well as reversing the overall recruitment of macrophages and the accumulation 
of pro-inflammatory cytokines [13, 16]. These changes may counter the direct pro-inflammatory 
effects of IL-33 on adipocytes. 
4.1 Conclusions 
IL-33 has selective actions on GPR fatty acid receptor gene expression in human adipocytes, 
stimulating expression of the pro-inflammatory receptor GPR84. IL-33 also has extensive effects 
on the production of key cytokines and chemokines in human adipocytes, with a powerful 
stimulatory action on the expression of CSF3 and the secretion of its protein product G-CSF. 
IL-33 may be a significant modulator of the inflammatory response in adipose tissue. 
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Legends to Figures 
 
Fig. 1.  Effect of IL-33 on (a) GPR84, (b) GPR120, and (c) GPR41 gene expression in human 
adipocytes. The adipocytes were incubated with IL-33 (5, 20, or 100 ng/ml) for either 3 or 24 h. 
The results, which are expressed as fold-changes in mRNA level in cells treated with IL-33 
relative to the respective control cells (no IL-33), are means + SE (bars) for 4-6 sets of 
adipocytes. *P<0.05, ***P<0.001 compared with the control cells at the same time point. 
 
Fig. 2.  Effect of IL-33 on cytokine and chemokine gene expression (a-f) and protein secretion 
(g, h) in human adipocytes. The adipocytes were incubated with IL-33 (5, 20, or 100 ng/ml) for 
either 3 or 24 h. (a) IL1B, (b) CXCL2, (c) CCL2, (d) IL6, (e) CSF3, and (f) ADIPOQ gene 
expression. The gene expression results are fold-changes in mRNA level in cells treated with IL-
33 relative to the respective control cells (no IL-33). The amount of protein was measured in the 
medium for  IL-6 (g) and G-CSF (h). All results are means + SE (bars) for 4-6 sets of adipocytes. 
*P<0.05, **P<0.01, ***P<0.001 compared with the control cells at the same time point. 
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